Form 4: Twist Bioscience SVP Executes Pre-Planned Stock Sale

Twist Bioscience's SVP of Human Resources, Paula Green, reported the sale of 39,404 shares of common stock under a Rule 10b5-1 plan.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corp. (TWST), reported the disposition of company common stock.
• The transaction involved the sale of 39,404 shares of common stock.
• The shares were sold at a weighted average price of $52.4 per share, with individual sales prices ranging from $52.27 to $52.64 per share.
• Following this transaction, Paula Green beneficially owns 126,041 shares of common stock.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• The reported transaction date was February 17, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it is an insider sale, the execution under a Rule 10b5-1 plan suggests a pre-planned transaction for personal financial management rather than a reaction to new company-specific information.

Negatives

• An insider, the SVP of Human Resources, sold a significant number of shares (39,404 shares). While executed under a Rule 10b5-1 plan, such sales can sometimes be perceived as a lack of confidence, though this is mitigated by the pre-planned nature.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by the market as they can sometimes signal management's perception of future company performance. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of a change in sentiment, as they are pre-scheduled for diversification or liquidity purposes rather than being reactive to immediate market conditions or non-public information.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, though the 10b5-1 plan mitigates negative implications, suggesting a routine financial management decision rather than a lack of confidence in the company's prospects.

Key Dates

Keywords

Twist Bioscience, TWST, Insider Trading, Form 4, Stock Sale, Paula Green, 10b5-1 Plan, Corporate Officer